Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petrou

Showing results (31-40 of 2,091) with videos related to

Pageof 210
Sort By:
Journal of Medical Economics|May 12, 2015
Crisis as a serendipity for change in Cyprus' healthcare servicesPanagiotis Petrou
Expert Opinion on Pharmacotherapy|May 12, 2015
Cost-effectiveness analysis of axitinib through a probabilistic decision modelPanagiotis Petrou
Pharmacoeconomics|July 6, 1996
Current controversies in the treatment of HIV infection and AIDS. An economic perspectiveS Petrou
Public Health|January 7, 2017
Financial crisis hangover in Cyprus: tracking the demand for utilization of mental health servicesP Petrou
Paediatric and Perinatal Epidemiology|March 16, 2019
Exploring the relationship between macroeconomic factors and perinatal outcomesStavros Petrou
Value in Health Regional Issues|August 5, 2019
The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots' Health: The Memorandum Is Dead, Long Live the MemorandumPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|October 16, 2018
Looking for Her (2+): A systematic review of the economic evaluations of Trastuzumab in early stage HER 2 positive breast cancerPanagiotis Petrou
Journal of Medical Economics|April 26, 2021
The tyranny of the SW quadrantPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|February 17, 2018
A systematic review of economic evaluations of tyrosine kinase inhibitors of vascular endothelial growth factor receptors, mammalian target of rapamycin inhibitors and programmed death-1 inhibitors in metastatic renal cell cancerPanagiotis Petrou
Cardiovascular & Hematological Agents in Medicinal Chemistry|December 4, 2014
Editorial: Novel oral anticoagulants; "all that glitters is not gold, or is it?"Emmanouil Petrou
Pageof 210

Showing results (31-40 of 2,091) with videos related to

Sort By:
Pageof 210
Journal of Medical Economics|May 12, 2015
Crisis as a serendipity for change in Cyprus' healthcare servicesPanagiotis Petrou
Expert Opinion on Pharmacotherapy|May 12, 2015
Cost-effectiveness analysis of axitinib through a probabilistic decision modelPanagiotis Petrou
Pharmacoeconomics|July 6, 1996
Current controversies in the treatment of HIV infection and AIDS. An economic perspectiveS Petrou
Public Health|January 7, 2017
Financial crisis hangover in Cyprus: tracking the demand for utilization of mental health servicesP Petrou
Paediatric and Perinatal Epidemiology|March 16, 2019
Exploring the relationship between macroeconomic factors and perinatal outcomesStavros Petrou
Value in Health Regional Issues|August 5, 2019
The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots' Health: The Memorandum Is Dead, Long Live the MemorandumPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|October 16, 2018
Looking for Her (2+): A systematic review of the economic evaluations of Trastuzumab in early stage HER 2 positive breast cancerPanagiotis Petrou
Journal of Medical Economics|April 26, 2021
The tyranny of the SW quadrantPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|February 17, 2018
A systematic review of economic evaluations of tyrosine kinase inhibitors of vascular endothelial growth factor receptors, mammalian target of rapamycin inhibitors and programmed death-1 inhibitors in metastatic renal cell cancerPanagiotis Petrou
Cardiovascular & Hematological Agents in Medicinal Chemistry|December 4, 2014
Editorial: Novel oral anticoagulants; "all that glitters is not gold, or is it?"Emmanouil Petrou
Pageof 210